Business programme 2020

27 October 09:30–11:00
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Bolshoy hall
New Paradigm of Healthcare: Responding to Global Challenges
Plenary session The 2020 pandemic has created a number of economic and social challenges for governments and society, but has also demonstrated the soundness of the existing healthcare system and served as a powerful catalyst for its transformation. Effective and important regulatory initiatives and solutions have been implemented in a short time under difficult conditions, including a focus on digitalisation and remote formats of interaction with patients, the practice of inpatient substitution techniques, and the introduction of tools to sell drugs online, among others. Medical institutions in Russia have managed their work so that both patients with viral infections and patients who need routine care for chronic diseases can receive assistance in a fairly short time. This has all made it possible to take a fresh look at the utilisation of the resources that are being created as part of the national Healthcare project using both the country’s own potential and the experience of international cooperation. In the realities of the pandemic, improving human resource potential, searching for new approaches, and analysing current strategies in order to optimise and modernise them have become the key focuses of developing the healthcare system. This experience should be taken into account as much as possible and used in the future. Within the context of the patient-centred approach, the healthcare system of the future should contribute to the comprehensive improvement of all aspects of human life and health.
• How has the global healthcare system transformed throughout the world, and how has international experience influenced the effectiveness of decision-making in Russia during the pandemic?
• Which solutions will determine how the national healthcare system of the future develops?
• What revolutionary technologies and innovative approaches will have to be introduced in the healthcare system to reach the planned target numbers?
• What steps should be taken to promptly reform the system used to train and recruit medical personnel?
• What areas in the public healthcare system need to be transformed to help reach the new targets and provide the citizens of the Russian Federation with a long and high-quality life?
• How should responsibility for the health and longevity of the nation be distributed between the healthcare system, business, and citizens themselves?
Moderator:
Evelina Zakamskaya — Editor-in-Chief, Doctor Channel; Anchor, Russia 24
Evelina Zakamskaya was born on November 17, 1977, in Baku, and graduated from the Faculty of Philology at Tver State University. She is a presenter for Radio Mayak and for Mir, a television and radio company. Since 2006, she has been an anchor for television channel Russia 24. She writes and presents Mnenie (Opinion), a talk show covering social and political issues, and Idei, menyayushchie mir (World-Changing Ideas), a series of popular science programmes. Evelina Zakamskaya moderates Russia 24 sessions at major international forums. Since 2017 - Editor-in-Chief, Doctor Channel. She is married with two daughters.
Panellists:
Stanislav Voskresensky — Governor of Ivanovo Region
In 1998 graduated from Plekhanov Russian University of Economics with a degree in International Economic Relations.
1995-1999 – worked on tax issues in Russian and foreign assurance firms.
1999-2004 – Financial Director for organizations involved in specialized subterranean engineering and construction.
2004-2008 – Deputy Director of the President’s Expert Commission.
2008-2012 – Deputy Minister of Economic Development of the Russian Federation.
2012-2014 – Deputy Presidential Envoy to the Northwestern Federal District. He was responsible for coordinating the efforts of federal authorities in developing Kaliningrad Region.
Since August, 19, 2014 – Deputy Minister of Economic Development of the Russian Federation.
He heads the Russian Secretariat of the Intergovernmental Russian-Chinese Commission on Investment Cooperation. He heads the task force on the advancement of Russia’s economic Interests in the Asia-Pacific region under the Government Commission on Economic Development and Integration.
On October 10, 2018, assumed the post of Governor of the Ivanovo Region
Galina Karelova — Deputy Chairman of the Federation Council of the Federal Assembly of the Russian Federation
Deputy Chairperson of the Federation Council of the Russian Federation
Born on 29 June 1950 in the city of Nizhnyaya Salda, Sverdlovsk Region. In 1972, she graduated from the Sergei Kirov Urals Polytechnic Institute with a degree in engineering and economics. PhD in Economics and DSc in Social Sciences, professor. For 20 years she was engaged in teaching and research. Author of over 150 papers on economic, social and political issues.
Since 1990 – delegate, Deputy Speaker (1992–1993) of the Sverdlovsk Regional Parliamentarian Council.
1994–1996 – Deputy of the Council of Federation of the Federal Assembly of the Russian Federation, Chairperson of the Federation Council Committee on Social Policy.
1996–1997 – Deputy of the State Duma of the Federal Assembly of the Russian Federation, Chairman of the Subcommittee on International Humanitarian, Scientific and Cultural Cooperation of the State Duma Committee on International Affairs.
Since 1997 – Deputy and since 2000 – First Deputy Minister of Labour and Social Affairs of the Russian Federation.
April 2003 – March 2004 – Deputy Prime Minister of the Russian Federation on Social Affairs.
April 2004 – December 2007 – Chairperson of the Social Insurance Fund of the Russian Federation.
On 2 December 2007, she was elected a deputy to the Fifth State Duma, Deputy Speaker of the State Duma Committee on Budget and Taxes.
On 4 December 2011, she was elected a deputy to the Sixth State Duma, First Deputy Chair of the State Duma Committee on Labour, Social Policy and Veteran Affairs.
Since 22 September 2014, she is a Representative of the executive authority of the Voronezh Region in the Federation Council. Deputy Speaker of the Federation Council of the Federal Assembly of the Russian Federation, member of the Federation Council Committee on Social Policy. Initiator and drafter of more than 40 laws, including laws on social protection. Full State Counsellor 1st Class of the Russian Federation. Decorated with state orders and medals.
Hans Henri P. Kluge — Regional Director for Europe, World Health Organization
Mikhail Murashko — Minister of Health of the Russian Federation
Born on January 9, 1967 in Sverdlovsk.
1986-1988 – served in the USSR Army.
1992 – graduated from Ural State Medical Institute.
August 1992 – March 1996 – intern; Obstetrician Gynecologist, Komi Republic Hospital in Syktyvkar.
March 1996 – November 1996 – Deputy Medical Superintendent for Consulting and Diagnostics, Medical Superintendent, Komi Republic Perinatal Center in Syktyvkar.
November 1996 – December 1999 – Medical Superintendent, Komi Republic Medical Group in Syktyvkar.
January 2000 – March 2006 - Medical Superintendent, Komi Republic Perinatal Center under Komi Republic Agency of Health Care, Syktyvkar.
March 2006 – February 2011 – Minister of Health Care, Komi Republic.
February 2011 – June 2012 – Head of Department, Obstetrics and Gynecology Department (offers a course of pediatrics), Kirov State Medical Academy under the Ministry of health Care of the Russian Federation, Syktyvkar.
July 2012 – March 2013 – Deputy Head, Federal Service for Health Care Supervision, Moscow.
July 2013 – July 2015 – acting Head, Federal Service for Health Care Supervision.
July 14, 2015 till present time – Head of the Federal Service for Health Care Supervision (has the title of the Full State 2-nd Class Counsellor of the Russian Federation).
1999 – Doctor of Medicine.
2004 – postgraduate degrees in Obstetrics/Gynecology and Public Health Care Administration.
Board certified in Obstetrics/Gynecology and Public Health Care Administration.
Editor-in-Chief and Founder, Human Health in the North Journal. Editorial Board Member, Children’s Health Care in the North West Journal.
Anna Popova — Head, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
Ms. Popova, M.D., has a degree in medicine and prophylactics, professor in medical hygiene.
Worked as an epidemiologist, chief of epidemiology at Budennovsk hospital, chief epidiemologist in State Center in Serpukhov and Pushino, deputy head of Rospoterbnadzor in Moscow oblast, head of HR or Rospoterbnadzor and deputy chief of Rospotrebnadzor .
After a decree of the government of Russian Federation government N1931 temporary acted as chief of Federal Agency for consumer protection and human wellbeing from October 23, 2013.
Following a decree of the government of Russian Federation N571-p appointed head of Rospoterbnadzor.
Married, has two children
Sergey Tsyb — First Deputy Minister of Industry and Trade of the Russian Federation
Date of birth: 29 April 1968
Place of birth: Obninsk, Kaluga Region
Education: Graduated from G.V. Plekhanov Russian Academy of the Economics, PhD in Economics
Work history:
1991–2007: Executive positions in various businesses
2007–2008: Director, Chemical Technology Complex and Bio-Engineering Technology Department of the Ministry of Industry and Energy of the Russian Federation
2008–2013: Director, Chemical Technology Complex and Bio-Engineering Technology Department of the Ministry of Industry and Trade of the Russian Federation
Since 2013: Deputy Minister of Industry and Trade of the Russian Federation
Awards:
2009: Mercy honorary badge from the Ministry of Healthcare and Social Development of the Russian Federation
2011: Honorary Chemist title from the Ministry of Industry and Trade of the Russian Federation
2011: Prize of the Government of the Russian Federation in the field of science and technology for development and implementation of the scientific fundamentals of the national system of chemical product turnover safety
2015: Medal of the Service to the Motherland Order 2nd Degree
Civil rank: Full State Councillor of the Russian Federation, 1st Class
Front row participants:
Sofia Malyavina — General Director, National Priorities
Alexander Petrov — Chairman of Subcommittee on Medicines Circulation, Pharmaceutical and Medical Industry Development, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection
27 October 11:30–12:45
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Presidential hall
Identifying a Strategy for Demographic Development by 2030: Making Decisions in an Era of Upheaval
According to a decree of the President of the Russian Federation «On the country’s national development goals until 2030», the life expectancy of Russians by the target date should increase and reach 78 years. Such goals require the restoration of economic growth and improvements in social well-being and public health. The trend of dwindling birth rates remains the country’s key demographic problem. The goal of ensuring natural population growth and increasing life expectancy requires the healthcare system to implement a multidimensional review of approaches to demographic policy. These strategies are based on a whole range of tasks and the need for an integrated approach to their solutions - the equal access to high-quality and timely medical care (especially in primary care), the search for innovative solutions in medical science, the digitalization of healthcare, expanding the potential of high-tech care and others. It is still important for the government to focus on the implementation of incentive programmes to support young families and awareness-raising activities. In addition to promoting the values of a healthy lifestyle, mass physical education, and sports, an equally important task is to promote the culture of family and having several children among young people.
• What strategies should the government develop to overcome the consequences of the pandemic and ensure stability in demographic processes?
• How can we create an effective reproductive health system?
• What new models of healthcare will be able to provide an effective policy for the protection of motherhood and childhood?
• What measures can be used to reorient society towards a conscious desire to lead a healthy lifestyle and take care of their health?
Moderator:
Oleg Apolikhin — Chief Specialist of the Ministry of Health of the Russian Federation for Reproductive Health; Corresponding Member of the RAS; Doctor of Medical Sciences, Professor, Director, N.A. Lopatkin Research Institute of Urology and Interventional Radiology, a branch of the National Medical Research Centre for Radiology of the Ministry of Health of the Russian Federation
Apolikhin O.I. is a graduate of Voronezh State Medical Institute and has received his MD from the Scientific Research Institute of urology of the Health Ministry of Russia. He extended his education with several abroad trainings: Medical Technical University (ACTIM) France, Medical and Economic faculty, course in health care economics and new technologies and modern equipment utilization. Oxford University (England), MBA faculty, course in medical ethics and administrative law in health care. Oxford University (England), course in evidence based medicine. Professor Apolikhin is actively involved in state health care structure being chief specialist in Reproductive Health of the Ministry of Health Care of Russia. He systematically holds scientific, organizational and methodical activity in reproductive health in Russian regions. Professor Apolikhin has been recognized nationally and internationally through his international memberships which include European Urological Association, American Urological Association and Royal Society of Medicine (UK). He studied Administrative ethical issues in health care at Oxford University, where he also received MSc in evidence-based health care. Professor Apolikhin holds editorial positions on several well-respected journals, including Russian Journal of Urology. He has authored and co-authored more than 500 articles, edited and co-edited 10 books, has multiple multimedia presentations to his credit. His extensive experience in the field of urology and andrology has afforded him the opportunity to participate in academic activities, meetings and courses as a speaker and chairperson. Fields of his interest are postgraduate medical education upgrading, modernization of Russian health care system, men’s health evaluation and management.
Panellists:
Nikolay Govorin — Deputy Chairman of the Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection
Anna Kuznetsova — Presidential Commissioner for Children’s Rights
Oleg Nikolaev — Governor of the Chuvash Republic
Oleg Salagay — Deputy Minister of Health of the Russian Federation
Oleg Salagay, Candidate of Medical Sciences, Director of the Department of Public Health and Communications of the Ministry of Healthcare of the Russian Federation, Press Secretary of the Minister of Healthcare of the Russian Federation Veronika Skvortsova.
Born on 3 October 1983 in Irkutsk (Irkutsk Oblast).
In 2005, graduated with honours from Irkutsk State Medical University.
In 2006, graduated with honours from the Academy of Labour and Social Relations, Department of Law.
In 2010, graduated with honours from the Diplomatic Academy of Russian Foreign Ministry.
In 2011, received a Master’s Degree in European Law from Moscow State Institute of International Relations (MGIMO University) under the Ministry of Foreign Affairs of the Russian Federation.
Oleg Salagay is a member of many working groups under the auspices of the World Health Organization, BRICS, and bilateral cooperation. He is Chairman of the Conference of the Parties to the Framework Convention on Tobacco Control.
Front row participants:
Igor Buhtiyarov — Director, Izmerov Research Institute of Occupational Health
Kirill Litovchenko — Head, Expert Center for Demographic Policy and Reproductive Health, Delovaya Rossiya (Business Russia)
Alexander Mokhov — Head of the Medical Law Department, Kutafin Moscow State Law University (MSAL)
Lilia Ovcharova — Vice Rector, National Research University Higher School of Economics
Natalia Solovieva — Chairman, Association of Patients with Infertility
Evgeniy Shpeer — Medical Director of Vaccines, GSK Pharma Russia
Sergey Shulgin — Deputy Head of Research Laboratory for Science, International Laboratory of Demography and Human Capital, Institute of Applied Economic Research, Russian Academy of National Economy and Public Administration(RANEPA)
27 October 11:30–12:45
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Bolshoy hall
COVID-19 Vaccine: Working Towards the Goal
The pandemic has taken a heavy toll on the economy and public health around the world. To date, more than 21.5 million people have already been infected, and trillions of dollars in economic damage have been caused. Today, the world has accumulated scientific potential at the level of multinational pharmaceutical giants, small companies, and academic institutions in order to produce a vaccine that then has to be developed and brought to the international market in an unprecedented short time. The WHO has created an international platform to record clinical trials in order to coordinate and consolidate global efforts. Around 150 vaccines are currently being developed worldwide. In Russia, 17 research centres are working on vaccines, more than 26 types of vaccines are being developed. On 11 August 2020, the Russian Ministry of Health registered the world’s first Sputnik V vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology. The third stage of research on this vaccine is currently under way. In the near future, the second stage of successful clinical trials will be completed at the VECTOR State Research Centre of Virology and Biotechnology, after which post-registration studies of the drug will begin at the St. Petersburg Research Institute of Vaccines and Serums under the Federal Biomedical Agency and the Smorodintsev Research Institute of Influenza, which were among the first to begin clinical trials of drugs and have become national leaders in the creation of vaccines. The diversification strategy that is being applied worldwide and involves the development of several types of vaccines all at once has enabled us to adhere to the humanistic principles of efficacy and safety and to also identify the most promising areas for development. In the near future, the WHO should receive data on 8 to 9 vaccines in order to secure provisional pre-qualification, which will allow the authorities to launch a mass vaccination programme that may begin in the next month.
• To what extent should vaccines be produce to satisfy the Russian market? Does the country have sufficient industrial capacity to provide this volume?
• What is a realistic timeframe for the mass vaccination of Russians to begin? What criteria should be taken into account when developing a vaccination plan?
• Get vaccinated or get sick: what is the advantage of vaccination over the development of natural immunity?
• What government decisions are needed to meet the need for vaccines at the level of all the regions? Does the government plan to participate in funding for universal vaccination against COVID-19?
Moderator:
Sergey Brilev — Anchor, Deputy Director, Russia TV Channel; President, Bering Bellingshausen Institute for the Americas
Russian TV presenter, writer and public figure. Deputy Director of the Rossiya TV channel for special informational projects, President of the Bering-Bellingshausen Institute for Both Americas (Montevideo), member of the Praesidium of the Foreign and Defence Policy Council (Moscow), the only Russian journalist to have interviewed both the last two Presidents of the Russian Federation and the USA: Putin and Medvedev, Bush and Obama.
Born 24 July 1972 in Havana (Cuba).
Graduated from MGIMO MID RF (1995, Moscow), the Montevideo Institute of Foreign Languages (1991, Uruguay), and finished BBC courses (1995, London).
Career:
1990–1993: Komsomolskaya Pravda. Trainee, scholarship holder, correspondent-intern in the department of science and education.
1993–1995: Moscow News. International department special correspondent. In parallel, Moscow correspondent of the Uruguay El Observador Económico and the Argentinian La Razón, as well as Russian State Duma Latin America expert.
Since 1995: Rossiya (RTR) TV channel, including:
1995–1996: Vesti special correspondent (including during the First Chechen War).
1996–2001: Bureau Chief in London.
First broadcast as presenter on 11 September 2001 (day of the terrorist acts in the USA).
2001–2003: presenter of evening Vesti.
2003–2007: presenter of Vesti Nedeli, Deputy Director, Directorate of information programmes.
Since 2008: presenter of the Vesti on Saturday programme, Deputy Director of Rossiya TV channel.
Author of a multitude of documentary films: Secret of Three Oceans, Constitutional Practice, Duma Thinking, Right to Right, Heavy Oil, Another Coal, The Caribbean Crisis. An Incomprehensible Story, Nazarbayev’s Line, etc.
Author of the books: Forgotten Allies in World War II (2012) and Fidel. Football. Falklands (2008).
One of the main spheres of his professional activity is interviewing heads of state. In particular, in Latin America: Chavez (Venezuela), Ortega (Nicaragua), Correa (Ecuador), Morales (Bolivia), Sanguinetti (Uruguay), Bachelet (Chile) and so on.
By order of the Russian President, awarded the Order of Friendship, the medals 300th Anniversary of St. Petersburg and 1000th Anniversary of Kazan (2005). Was the finalist and winner of the TEFI awards many times.
Speaks English and Spanish fluently.
Panellists:
Melita Vujnovic — Representative to the Russian Federation, Head of Office, World Health Organization Office in the Russian Federation
Anna Popova — Head, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
Ms. Popova, M.D., has a degree in medicine and prophylactics, professor in medical hygiene.
Worked as an epidemiologist, chief of epidemiology at Budennovsk hospital, chief epidiemologist in State Center in Serpukhov and Pushino, deputy head of Rospoterbnadzor in Moscow oblast, head of HR or Rospoterbnadzor and deputy chief of Rospotrebnadzor .
After a decree of the government of Russian Federation government N1931 temporary acted as chief of Federal Agency for consumer protection and human wellbeing from October 23, 2013.
Following a decree of the government of Russian Federation N571-p appointed head of Rospoterbnadzor.
Married, has two children
Front row participants:
Natalya Belozerova — Head of Research and Development Center, St. Petersburg Research Institute of Vaccines and Serums and an Enterprise for the Production of Bacterial Preparations
Elena Gavrilova — Candidate of Biological Sciences; Deputy Director for Research, State Research Center of Virology and Biotechnology VECTOR of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
Ekaterina Efimova — Head of Social Projects, National Priorities
Denis Logunov — Doctor of Biological Sciences, Russian Academy of Sciences corresponding member; Deputy Director for Science, National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation
27 October 11:30–12:45
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Malyy hall
Lessons from the Pandemic: Time for Quick Decisions Without Any Room for Mistakes
The 2020 pandemic disrupted the normal lifestyle of millions of people overnight, splitting time into ‘before’ and ‘after’, and forever altering political, economic and social life. Perhaps historically it will be thought of as a crisis that led to a global reboot of all systems. Everyone faced unprecedented challenges – states, business, society, and every single person. The key factors in the successful response to the pandemic were the speed of decision-making by the public authorities and the effectiveness of the healthcare system, which showed resilience and flexibility and was able to respond to global challenges with a number of effective solutions. One of the results of the global transformations in the industry is the way in which society’s attitude towards doctors has changed, with medicine turning from a service sector into a safety zone. The 2020 crisis has hit the economy hard and has forced businesses to show strategic flexibility and significantly reshape existing business models and develop effective long-term strategies that can confront new economic challenges. The epidemiological situation has forced most companies to shift employees to a new work mode, which has become a requisite precondition for reformatting the labor market and the emergence of numerous socially oriented initiatives. The most important changes have affected social models and value systems, as the needs of other people have become the focus of attention, and the importance of human life has become the main value of this year.
The lessons of the pandemic have set the stage for future progressive changes, which are already overdue.

• What global health reforms have the pandemic identified as essential?
• Has the healthcare system been able to develop immunity to future emergencies and is it ready to respond to sanitary and epidemiological challenges?
• Will the pandemic accelerate the transition of the health system to a patient-centered approach?
• Does the Russian economy have enough potential to overcome the pandemic crisis and achieve the national goal of protecting the population along with people’s health and wellbeing?
• What areas of entrepreneurship development are most likely in the ‘post-crisis era’ and will businesses be able to build sustainable business models in the new reality?
• Will the increased stress factors during the year of the pandemic affect people’s physical and psychological health in the future?
• Will the social initiatives that emerged during the pandemic become the norm for the socioeconomic model of the future?
Moderator:
Alena Rogozina — Special Correspondent, Russia-1 TV Channel; Nominee for TEFI National Television Award
Panellists:
Yuriy Zhulev — President, Russian Hemophilia Society
In 1985, graduated from the school number 856 (Moscow).
In 1991, graduated from the Moscow State Law University.
In 1989, he was elected Vice President of Hemophilia Association (later renamed Hemophilia Society) that was established the same year.
Since 1993, he was the President of the Hemophilia Society.
In 2000, at the founding congress of the Russian Hemophilia Society he was elected its President, and he still holds this position.
In 2002–2004, he was a board member of the European Hemophilia Consortium and member of the World Federation of Hemophilia. He was named ‘Best volunteer’ of the World Federation of Hemophilia for his active work in CIS countries.
At present, he also holds the following positions:
• Co-chairman of the Russian Union of Patients Public Societies;
• Member of Commission for the Disabled under President of the Russian Federation;
• Head of the working group for improvement of the state sociomedical assessment system and monitoring of implementation of decisions made for the Commission for the Disabled under President of the Russian Federation;
• Co-chair of the Council of public agencies for patients’ rights for the Ministry of Health of the Russian Federation;
• Deputy Chairman of the Public Council of the Ministry of Health of the Russian Federation;
• Member of Council of public agencies for patients’ rights for Federal Service for Surveillance in Healthcare;
• Member of Moscow’s regional department of All-Russia People's Front.
Yury Zhulyov was awarded with an honorary certificate by the Ministry of Health of the Russian Federation, an honorary certificate by the Federal Service for Surveillance in Healthcare and Social Development.
Georgy Kostyuk — Chief Physician, Alekseyev Psychiatric Clinical Hospital No. 1 of the Moscow City Health Department
Andrei Nazarov — Prime Minister of the Government of the Republic of Bashkortostan
Andrey Nikitin — Governor of Novgorod Region
Born in 1979 in Moscow.
2001 – graduated from State University of Management.
2007 – was awarded EMBA degree at Stockholm school of Economics.
2002-2011 – held key positions in Ruskompozit Group of companies composed of the largest Russian enterprises which do business in the markets of glass fibre, composite and geosynthetic materials.
2009 — was appointed Director General of Ruskompozit Management Company LLC.
Since 27.07.2011 – held a position of the CEO of the Agency of Strategic Initiatives (ASI).
13.02.2017 – was appointed the acting governor of the Novgorod region by the Presidential Decree.
Member of the Presidium of the Council under the President of the Russian Federation for economic modernization and innovative development of Russia.
Member of the Presidium of the Presidential Council for Strategic Development and Priority Projects.
Member of the Supervisory Board of the Agency for Strategic Initiatives to Promote New Projects.
Awarded the Order "For Merit to the Fatherland" II class and the Russian Federation Presidential Certificate of Gratitude.
Ph.D. degree in Economics.
Married.
Ekaterina Pogodina — Director General, Johnson & Johnson Russia & CIS, Managing Director, Janssen, pharmaceutical division of Johnson & Johnson, Russia & CIS
Katerina began her career with Janssen in 2001, holding a number of positions in the Sales, Marketing and Market Access teams. She has been a member of the Russian board of directors since 2010 and was appointed Country Manager Russia in 2015, and then she was promoted to the position of Managing Director Russia & CIS in 2017. In April 2019 Katerina was appointed CEO of Johnson & Johnson Russia & CIS.

Throughout her 17-year career with Janssen, Katerina has consistently demonstrated high standards of quality and strong results. She led the launch of a whole range of new products and work across a number of therapeutic areas, as well as establishing several new business units. In her role as Commercial Operations Director, Russia, Katerina successfully led commercial teams in close collaboration with other departments, which yielded great business results and drove the company’s overall success.

Katerina graduated with distinction from the International University in Moscow, where she studied law. She also completed specialist education for senior executives at the London School of Economics and Political Science and Moscow School of Management Skolkovo.

Since 2015 Katerina has been a member of the board of directors of the Association of International Pharmaceutical Manufacturers (AIPM). Forbes magazine contributor, speaker of the Second Eurasian Women’s Forum.
27 October 13:15–14:30
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Bolshoy hall
Type 2 Diabetes: A Key Focus of Public Responsibility
According to WHO forecasts, diabetes will be the seventh leading cause of death on the planet by 2030. The number of cases is constantly growing, which increases the financial burden on national economies. In Russia, the number of patients with diabetes has increased by 23 percent over the past five years and stood at 4.8 million people in 2019. The trend towards obesity and set patterns of social behaviour, such as sedentary lifestyles, bad habits, and unhealthy diets, are contributing to the unhindered spread of type II diabetes. Today, as we combat the new coronavirus infection, studies of the aggravating factors of COVID-19 have shown that about 25% of people with a severe form of the disease suffered from diabetes. Considering that high blood sugar weakens the immune system, people with diabetes are at increased risk of complications. Over the period from 1996 to 2012, Russia implemented the federal targeted programmes ‘Diabetes Mellitus’ and ‘Prevention and Control of Socially Significant Diseases’. The measures that were carried out significantly reorganized and structured the diabetological service and helped to increase the life expectancy of patients with diabetes to 74.1 years.
• What should the federal targeted programme to combat diabetes aim to achieve first and foremost?
• How can the percentage of disability among patients with Diabetes Mellitus be reduced?
• How can we raise public awareness about the disease and develop a responsible attitude to people’s own health?
• How can we reduce the risk of severe coronavirus in diabetic patients?
• What additional preventive measures are required for patients with diabetes?
• What effective practices in this area are the regions ready to implement?
Moderator:
Evelina Zakamskaya — Editor-in-Chief, Doctor Channel; Anchor, Russia 24
Evelina Zakamskaya was born on November 17, 1977, in Baku, and graduated from the Faculty of Philology at Tver State University. She is a presenter for Radio Mayak and for Mir, a television and radio company. Since 2006, she has been an anchor for television channel Russia 24. She writes and presents Mnenie (Opinion), a talk show covering social and political issues, and Idei, menyayushchie mir (World-Changing Ideas), a series of popular science programmes. Evelina Zakamskaya moderates Russia 24 sessions at major international forums. Since 2017 - Editor-in-Chief, Doctor Channel. She is married with two daughters.
Panellists:
Joao Breda — Head of the European Office, World Health Organization for the Prevention and Control of NCDs
Francesco Giorgino — President, Italian Society of Endocrinology (SIE); Professor of Endocrinology and Chief, Division of Endocrinology University Hospital Policlinico Consorziale, University of Bari Aldo Moro
Francesco Giorgino is Professor of Endocrinology and Metabolism and Chairman of the Department of Emergency and Organ Transplantation at the University of Bari Aldo Moro, Bari, Italy. He is also Chief of the Division of Endocrinology at the University Hospital Policlinico Consorziale in Bari, Italy. Professor Giorgino received his M.D. degree from the University of Bari Aldo Moro and his Ph.D. degree from the University of Naples Federico II, in Italy. After completing clinical and research training in endocrinology and metabolism at the University of Catania, Italy, he worked for several years at the Joslin Diabetes Center and Harvard Medical School in Boston, MA, USA, first as a postdoctoral research fellow and then as a visiting scientist.

Professor Giorgino has received distinguished scientific awards from various international and national institutions, including the Juvenile Diabetes Research Foundation International (JDRF) Fellowship (New York, NY, USA), the Mary K. Iacocca Foundation Fellowship (Boston, MA, USA), the Glaxo-Wellcome Award from the European Association for the Study of Diabetes (EASD), the Aldo Pinchera and Cassano Awards from the Italian Society of Endocrinology, and the Alcmeone Award from the Italian Society of Diabetology. He has been the Italian Delegate in various European Commission Cooperation in Science and Technology (COST) actions for diabetes research. Professor Giorgino has served on many national commissions and national boards, including the Executive Committees and Scientific Committees of the Italian Society of Diabetology and of the Italian Society of Endocrinology. He is currently President of the Italian Society of Endocrinology.

He is or has been a member of the Editorial Boards for the following journals: PLoS ONE, Journal of Endocrinology, Endocrinology, Journal of Endocrinological Investigation, Adipocyte, Acta Diabetologica, Cardiorenal Medicine, and Diabetes Metabolism Research and Reviews. He has published more than 200 original and review articles in prestigious scientific journals and has been an invited speaker at many national and international meetings. Professor Giorgino’s research interests include the mechanisms leading to insulin resistance and beta-cell dysfunction in type 2 diabetes with a particular focus on skeletal muscle metabolism and organ cross-talk, inflammation and lipotoxicity, and the effects of diabetes drugs on pancreatic islets and the cardiovascular system. He has also been involved in several clinical trials investigating the effects of glucose-lowering drugs in individuals with type 2 diabetes. He has an H-index of 58 and over 11,000 citations (Google Scholar).
Hans Duijf — Vice-President, Russia and Belarus, Novo Nordisk
Hans Duijf was appointed Vice President of Novo Nordisk in Russia and Belarus since September 1, 2017.
Mr. Duijf is a Dutch national, born in June 1974. He moved to Moscow with his family, wife and two daughters, from Colombia, where he held the position of General Manager of the Novo Nordisk affiliate since 2015.
Mr. Duijf has nearly 20 years of experience in the affiliates and regional headquarters of Novo Nordisk in established and developing markets in Europe, South-East Asia and Latin America. Under his leadership diverse teams of different cultures consistently succeeded in improving performance and introducing innovative approaches. Mr. Duijf began his career in sales and marketing in the UK, and later participated in the product launching in the markets of different countries. He has extensive management experience in positions such as Marketing Director, Business Development Director, General Manager, Vice President.
Hans Duijf has received education in international marketing and strategic management and holds a Master of Science (M.Sc.) degree in Business Administration from Rotterdam School of Management, Erasmus University in the Netherlands.
Oliver Koehncke — General Director, Boehringer Ingelheim Russia
Alexander Mayorov — President, Russian Diabetes Association
Simon Matskeplishvili — Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology
Simon Matskeplishvili, MD, PhD, FESC, FACC, is a Professor of Cardiology and a Chief Scientific and Clinical Researcher at the Bakoulev Scientific Center for Cardiovascular Surgery in Moscow and an adjunct professor of life sciences at the Moscow Institute of Physics and Technology.
He also serves as a member of the Education, Certification and Accreditation, European Communities Committees of the European Association of Cardiovascular Imaging.
He graduated with honors from the Moscow Medical Academy in 1994 and had his postgraduate training and fellowship in cardiology at the Clinico-Diagnostic Department of the Bakoulev Center.
In 1997-1998 he received a degree of the International Master in Cardiology from the Institute of Clinical Physiology of the National Research Council of Italy in Pisa.
Simon Matskeplishvili is a Fellow of the European Society of Cardiology and a Fellow of the American College of Cardiology. He has received numerous honours and awards, both in Russia and internationally, including the European Cardiology award in 2001. He is a founder and a Chairman of the echocardiography section of the Russian society of cardiology. In 2007 he became a full professor of cardiology.
For the development of new non-invasive method of intracardiac blood flow evaluation in 2012 he was awarded a State Prize of the Government of Russian Federation in science and technology.
In 2013 he was a captain of the Russian team to win an ESC Cardiology Quiz “Primus inter pares” at the European Congress of Cardiology in Amsterdam.
In 2012 Professor Simon Matskeplishvili had organized and implemented the Educational Program for cardiologists and internal medicine physicians in Moscow. He also conducts an English-language elective course “Amazing Cardiology” in cardiology, cardiac surgery and cardiovascular imaging at the Faculty of Medicine of the Lomonosov Moscow State University.
The Board of the European Society of Cardiology has appointed Simon Matskeplishvili as the Coordinator of the Congress Programme Committee of the European Society of Cardiology Congress 2015-2016.
Oleg Salagay — Deputy Minister of Health of the Russian Federation
Oleg Salagay, Candidate of Medical Sciences, Director of the Department of Public Health and Communications of the Ministry of Healthcare of the Russian Federation, Press Secretary of the Minister of Healthcare of the Russian Federation Veronika Skvortsova.
Born on 3 October 1983 in Irkutsk (Irkutsk Oblast).
In 2005, graduated with honours from Irkutsk State Medical University.
In 2006, graduated with honours from the Academy of Labour and Social Relations, Department of Law.
In 2010, graduated with honours from the Diplomatic Academy of Russian Foreign Ministry.
In 2011, received a Master’s Degree in European Law from Moscow State Institute of International Relations (MGIMO University) under the Ministry of Foreign Affairs of the Russian Federation.
Oleg Salagay is a member of many working groups under the auspices of the World Health Organization, BRICS, and bilateral cooperation. He is Chairman of the Conference of the Parties to the Framework Convention on Tobacco Control.
Marina Shestakova — Deputy Director of the Center- of the Diabetes Institute, Endocrinology Research Centre of the Ministry of Health of the Russian Federation
Front row participants:
Oksana Drapkina — Director, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks
Andrey Prilutskiy — Minister of Healthcare of Ryazan Region
Patimat Khandaeva — Chair, Russian Young Endocrinologists Society (RYES)
27 October 13:15–14:30
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Malyy hall
Countering COVID-19: New Formats in the Fight against Cancer
The healthcare system has faced an unprecedented challenge since the start of 2020. In order to combat coronavirus, several medical institutions have had to be repurposed in a short time, while maintaining the availability of medical care for cancer patients. In the context of mitigating the consequences of the 2020 pandemic, one of the key goals of the national project to reduce mortality from neoplasms not only requires the active introduction of advanced methods of prevention, diagnosis, and therapy into medical practice, but also the creation of an ecosystem for cancer care, the development of fundamentally new approaches to such care, tools for expanding access to therapy, and the introduction of innovative funding models by connecting businesses and sharing risks. Such new formats include the launch of a network of Outpatient Oncological Care Centres in the regions as well as a vertically integrated system that allows for ensuring continuity between institutions, prescribing the most modern treatment to the patient, and, if necessary, requesting a second opinion. In 2020, the federal project to combat cancer includes oncohematology. Thanks to the use of advanced modern drug therapy, patients with lymphatic and hematopoietic tissue neoplasms are more likely to receive effective medical care compared with other cancer patients.
• What new approaches and tools have been the most effective in providing healthcare during the pandemic?
• What solutions have become the basis for the development of a new paradigm of cancer care?
• How can the availability of diagnostics and modern therapy be enhanced for cancer patients?
• What tools are being implemented in Russia for the development of outpatient oncology?
• How will AI and innovative technologies change the way cancer patients are treated?
• How promising is the idea of introducing innovative financial solutions and attracting private investment and valid for the development of cancer care?
Moderator:
Alexander Petrov — Chairman of Subcommittee on Medicines Circulation, Pharmaceutical and Medical Industry Development, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection
Panellists:
George Zaki — Head of Oncology, EEMEA MSD
Andrey Kaprin — Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
· Doctor of Medical Sciences, Professor, Academician of RAS, Honored Doctor of the Russian Federation.
· Director General of the National Medical Research Radiological Centre (NMRRC) of Ministry of Health of the Russian Federation, Director of the P.A. Herzen Moscow Cancer Research Institute, a branch of NMRRC.
· He is one of the leading specialists in the Russian Federation in the field of diagnosis and treatment of oncological diseases. Throughout the scientific and therapeutic activity, Andrey Kaprin conducts a purposeful development of modern methods of surgical and combined treatment of kidney, bladder, prostate and other localizations.
· Since 2014, Andrey Kaprin is heaing the first Russian scientific medical cluster in the field of oncology - the Federal State Budgetary Institution "National Medical Research Radiological Centre" of Ministry of Health of the Russian Federation, which was established on the basis of three leading medical centers - P. Herzen, A.Tsyb MRRC, and N. Lopatkin Research Institute of Urology and Interventional Radiology.
· At present, being the head of the NMRRC of Ministry of Health of the Russian Federation, being an academician of the Russian Academy of Sciences in oncoradiology, he supervises the development of nuclear medicine, radiology and radiotherapy in our country. He has taken charge of most complex and promising areas in the industry: the technical re-equipment of the radiation therapy departments of the regions, the creation of a program and a center for the development of contact methods of irradiation, the introduction and expansion of the first national medical proton center in the country, the introduction of modern methods of training specialists in radiology and radiotherapy, iIncluding telecommunication training and master classes in the regions, many of which are conducted by himself.
· Every year Andrey Kaprin performs over 300 complex surgical interventions for various oncological diseases.
· He has trained more than 300 doctors, including residents and graduate students. Under his leadership, 27 dissertations for the degree of candidate of medical sciences and 9 doctoral dissertations were prepared and successfully defended. The result of many years of hard work was the publication of more than 700 printed scientific works.
David Melik-Guseinov — Deputy Governor of the Nizhny Novgorod Region, Minister of Health of the Nizhny Novgorod Region
Alexander Petrovskiy — Deputy Director for Educational Activities, National Medical Research Center of Oncology named after N. N. Blokhina of the Ministry of Health of the Russian Federation
Carina Ferreira-Borges — Programme Manager, World Health Organization European Office for the Prevention and Control of Noncommunicable Diseases
Front row participants:
Alisa Dzhangiryants — Director of Market Access and Pricing, Bristol-Myers Squibb
Nikolay Dronov — Chairman of the Coordination Council, "Movement Against Cancer"
Dmitry Kudrumov — First Deputy Chairman of the Government of Kirov Region
Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Aleksandr Rumyantsev — President, Dmitry Rogachev National Research Centre
Alexander Rumyantsev, born in 1947, is a Russian Doctor of Medical Sciences, professor, member of the Russian Academy of Sciences, General Director of the Dmitry Rogachev National Research Centre of Pediatric Hematology, Oncology and Immunology, member of the Board of the ‘Doctors, Innovation and Science for Children’ Foundation that supports the development of Pediatric Hematology, Oncology and Immunology, chief consulting pediatric hematologist of the Ministry of Health of Russia, President of the National Society of Pediatric Hematologists and Oncologists, Chairman of the Board of the National Association of Experts in Primary Immunodeficiency, Vice President of the National Medical Chamber, Honorary Professor of the Department of Oncology and Hematology of the School of Pediatrics of Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. Graduated with honours from the Russian National Research Medical University named after N.I. Pirogov in 1971.
Alexander Rumyantsev is an active facilitator of medical science and practice. For years he headed the RSMU scientific programmes on leukemia in humans and animals of the USSR Committee for Science and Technology and research on rectifying the consequences of Chernobyl disaster, was a member of the Academic Council of the Academy of Medical Sciences and the Ministry of Health of the USSR on pediatrics, hematology and oncology. From 1989 to the present day he has been a Chairman of the hematology section of the Moscow Society of Pediatric Physicians. He is a participant of the Chernobyl nuclear disaster elimination team (1986–1987), ‘Children of Chernobyl’ research programme facilitator in the USSR (1990–1991) and in Russia (1991–1995). Rumyantsev for twenty five years has led pediatric hematology/oncology services in Russia, the process of preparation and adoption of the industry development and financing programme, successful treatment of leukemia, malignant lymphomas, brain tumours, other neoplasms in children and adolescents, setting up a course on pediatric hematology/oncology in the School of Continuing Medical Education in RSMU (the Department of Clinical Hematology/Oncology and Immunology of the School of Continuing Medical Education in RSMU since 2004, and the Department of Oncology and Hematology of the School of Pediatrics of the RSMU), the groundwork for academic programme, the training and certification of pediatric hematologists/oncologists in the Russian Federation.
As a researcher, Alexander Rumyantsev is known for his works in pediatric hematology and immunology, medical ecology, intensive and outpatient pediatrics, adolescent medicine and organization of public health, clinical physiology and pathophysiology of blood, regulation of hematopoiesis and immune response, pathogenesis and treatment of hereditary and evoked blood diseases in children, intensive polychemotherapy and immunotherapy of leukemia. Alexander Rumyantsev is the author of more than 650 scientific papers, including 45 monographs and manuals. He is a member of the Scientific Council and the head of the scientific platform ‘Oncology’ of the Ministry of Health of the Russian Federation, the editor-in-chief of the Bulletin of Blood Service in Russia journal, a member of editorial boards of the following journals: Pediatrics, Russian Pediatric Journal, Issues of Practical Pediatrics, Issues of Dietary Therapy In Pediatrics, Issues of Hematology/Oncology And Immunopathology In Pediatrics, Hematology And Transfusiology, Russian Journal of Pediatric Hematology and Oncology, School of Health, Russian Journal of Immunology; member of the Pharmaceutical Committee of the Russian Federation; member of the National Council of Experts on Rare Diseases, advised 70 doctors and 128 candidates of medical sciences. Honourable Laureate of the Russian National Research Medical University awards (1978, 1983, 1994, 2007), of the Maslov Academy of Medical Sciences of the USSR (1978), of the Moscow Komsomol (1979) for the research in hematology and immunology. He was awarded with a participant’s diploma and a silver medal of the VDNKh (All-Union Exhibition of Achievements of National Economy) (1989) for development of diagnostics and immunotherapy of blood diseases in children, and with an honorary medal of the University of Montpellier (France, 1990). In 1994 he was awarded the Order of Friendship of Peoples for his scientific and academic work, in 2002 – the Honorary Diplomas of the State Duma of the Russian Federation and the Moscow City Duma, in 2003 and 2015 – ‘The Calling’ Award for the best doctors in Russia, in 2004 – the medal ‘For Merits in Healthcare’, in 2007 – Excellent Worker of Public Health badge. In 2008 and 2011 he received the medical awards from the Moscow government, in 2013 – the International Galien Award. In 2015 he was awarded the Glory of Ossetia Order and the Russian Emergencies Ministry (EMERCOM) medal ‘Cooperation for Salvation’.
Married with two children and five grandchildren.
27 October 13:15–14:30
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Presidential hall
The COVID-19 Pandemic: The Challenge to Modern Science
The rapid spread of COVID-19 has posed enormous challenges around the world. In the fight against the virus, science in particular has been on the front line. The pandemic has led to a rapid increase in research in the fields of microbiology, virology, genetics, and coronavirus testing and screening. This has in turn facilitated the coordination and consolidation of all available resources in an attempt to expedite the process of identifying methods of prevention and treatment.
The Russian Federation was one of the first nations to develop a high sensitivity and specificity test for COVID-19, doing so within a very short timeframe. The scientific community in Russia also developed and registered the world’s first COVID-19 vaccines. And the work done by scientists in the country to study samples of the virus has made a notable contribution to monitoring pathogen variability around the world.
Science is key to tackling the pandemic. It enables us to understand what we are up against, to study its weaknesses, and to take proactive measures.
• In the 10 months since COVID-19 was identified, what knowledge about the virus has been obtained thanks to the efforts of the scientific community?
• What areas of scientific research on COVID-19 hold the most promise and are most in need?
• Given the huge number of studies and papers published, how is it possible to determine which ones are significant and offer practical application? What can be done to ensure that the information obtained is accurate?
• What can be done to coordinate the research being done in the public and private sectors?
Moderator:
Inna Finochka — Head of Healthcare, Information Portal “Future of Russia. National projects”
Panellists:
Aleksandr Gorelov — Corresponding Member of Russian Academy of Sciences; Head of the Clinical Department of Infectious Pathology, "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance
Vladimir Kutyrev — Director, Russian Anti-Plague Scientific Research Institute "Microbe"
Areg Totolian — Director, Institut Pasteur in St. Petersburg for Research in Epidemiology and Microbiology of Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
Director of Saint-Petersburg Pasteur Institute, Head of the Laboratory of Molecular Immunology, Professor (2003), Corresponding member of the Russian Academy of Medical Sciences (2011), Corresponding member of the Russian Academy of Sciences (2014), academician of the Russian Academy of Sciences (2016)
Areg A.Totolian was born on 27 December 1958 in Yerevan (Armenia), and moved to Leningrad (Saint-Petersburg) in 1964.
In 1975 he entered the First Pavlov Medical Institute of Leningrad (The First Pavlov State Medical University of St. Petersburg /PSPbGMU) where he worked until 2008. He was trained and acquired his professional experience in the fields of internal diseases, pulmonology and general and clinical laboratory immunology.
In 1986 А. Totolian organized a Clinical Immunology Laboratory run by him until 2000; by authorization of the Ministry of Public Health of the Russian Federation, organized, at the premises of the PSPbGMU, a Research Guidance Centre of the Ministry of Public Health of the Russian Federation for Molecular Medicine (headed by him until 2008).
In 1987 he passed Ph.D. defence on pulmonology and immunology; in 1997 - earned his doctorate in immunology (concerned with the development of approaches and methodology of laboratory immunological diagnosis for diseases at the base of the achievements of fundamental immunology, immunochemical and molecular technologies).
From 1993 to 1995 he received training in infectious immunology at Istituto Superiore di Sanita (Rome, Italy).
For the first time in Russia, under the supervision of A. Totolian, 12 specialized immune programs were developed and since 2002 put into practice of the Federal System for External Quality Assessment of Clinical Laboratory Tests.
Under his direction 27 PhD theses and two doctorate theses were defended dealing with the strategy and methods of laboratory immune diagnosis; He is the author and a co-author of more than 440 research papers and 13 patents.
Since 2008, А. Totolian have been the Deputy Director for Research, the Director of the Laboratory of Molecular Immunology and Seroepidemiology (since 2016 - Laboratory of Molecular Immunology); since 2015 - the Director and interim of the Saint-Petersburg Pasteur Institute.
His main research activities are combined with teaching in PSPbGMU, here since 2013, he has directed the curriculum of clinical immunology and since 2015 has headed the Department of Immunology.
A. Totolian is an independent allergologist and immunologist at the Public Health Committee of the Government of St. Petersburg, Chairman of the Board of the regional office of the Russian Association of Allergologists and Clinical Immunologists in St. Petersburg (since 2017); Member of the Board of Directors of the Russian Scientific Society for Immunology and of All-Russian Scientific Society of Epidemiologists, Microbiologists and Parasitologists; member of the Board the Russian Scientific Society of Clinical Laboratory Diagnosis.
A. Totolian is Editor in Chief of the Infection and Immunity journal, deputy editor-in-chief of the Medical Immunology journal, member of the editorial boards and editorial teams of Clinical laboratory diagnostics, Journal of Microbiology, Epidemiology and Immunobiology, HIV infection and immunosupressions, Molecular Medicine, Cytokines and Inflammation, Russian Journal of Immunology journals.
A. Totolian participated in the establishment of the Department of the Russian Association of Allergologists and Clinical Immunologists in St. Petersburg, initiated and organized the annual (since 1997) All-Russia scientific forum with international participation Days of immunology in St.-Petersburg, and the annual (since 2010) All-Russian scientific school on Clinical Immunology Immunology for physicians in Pushkinskiye Gory (Pskov region).
In accordance with the decision of the Committee on Science and Higher Education of the Government of Saint Petersburg, the team led by A. Totolian was officially registered in 2013 as a scientific school in the field of Medical Immunology and Clinical Laboratory Diagnosis, and included in the Register of the Leading Scientific and Pedagogical Schools of St. Petersburg.
In 2013 А. Totolian received the gold medal from the Russian Scientific Society for Immunology for phenomenal achievements in the field of immunology.
In 2016 А. Totolian became the academician of the Russian Academy of Sciences.
He is married, has 2 children.
27 October 15:00–16:15
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Bolshoy hall
HIV and COVID-19: Enhanced Risk Control
Even with the challenges that the 2020 pandemic has caused for national health systems, we must not forget that the spread of HIV is one of the most significant global problems that pose a threat to the health and life of the global population. According to the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, the number of people with HIV in Russia this year has already exceeded 1 million people. Per the temporary recommendations of the Russian Ministry of Health on the prevention, diagnosis, and treatment of the novel coronavirus infection, patients with immunodeficiency conditions, including HIV without antiretroviral therapy, are at risk. In the context of the pandemic, the sufficiency and continuity of antiretroviral therapy during isolation as well as the provision of measures to reduce and prevent the risk of infection has taken on even greater importance. In an effort to study the effects of the new coronavirus pandemic on medical assistance for HIV treatment, the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing launched a nationwide study to identify the number of HIV-infected Russians who have had COVID-19, the testing experience on COVID-19, and whether there are risks of being infected with coronavirus and suffering comorbidities.
• Will the COVID-19 pandemic cause an increase in the number of people living with HIV in the near future and can its impact be prevented in this case?
• Are the measures being taken sufficient to achieve the goals of the government’s HIV spread prevention strategy?
• What new solutions are needed to improve the effectiveness of measures to reduce the number of new HIV infections and AIDS-related deaths?
• What measures can be implemented to ensure the availability of antiretroviral drugs during the pandemic?
• What impact has the use of HIV drugs for coronavirus treatment affected their availability?
Moderator:
Elena Voytsekhovskaya — Anchor, Doctor Channel
Panellists:
Marwan Akar — Managing Director, MSD Russia and EAEU
Г-н Акар начал работу в MSD в качестве инженера-технолога производства. По мере развития карьеры он занимал разные должности с возрастающей сферой ответственности, руководил проектами по трансферу технологий производства вакцин и других лекарственных препаратов, способствовал наращиванию производственных мощностей MSD и компаний-партнеров по всему миру.
В 2008 году г-н Акар был назначен на пост руководителя операций производственного подразделения MSD в регионах «Восточная Европа, Ближний Восток и Африка» и «Европа и Канада». В этой роли он поддерживал стратегические проекты по развитию бизнеса, а также отвечал за партнерства с локальными производителями, в том числе в России.
Г-н Акар получил диплом магистра в Мэрилэндском университете (США) по специальности «Химик-технолог». Он также закончил обучение по программе МВА (Магистр делового администрирования) в Имперском колледже Лондона.
Igor Borisevich — Deputy Head, Federal Medical-Biological Agency of the Russian Federation
Oleg Gridnev — Deputy Minister of Health of the Russian Federation
Alexey Mazus — Chief External Expert in HIV Diagnosis and Treatment of the Ministry of Health of the Russian Federation
Ruslan Malyuta — HIV/AIDS Specialist, UNICEF Regional Office for Eastern Europe and Central Asia
Nicole Seguy — HIV and Hepatitis Unit Lead, World Health Organization Regional Office for Europe
Front row participants:
Denis Godlevsky — Director, Regional Public Organization "AIDS, Statistics, Health"
Yulia Godunova — Director, EVA Association
Denis Gusev — Chief Doctor, Clinical Infectious Diseases Hospital named after S.P. Botkin
Kamil Saytkulov — Head of Communications and Government Affairs, GSK Russia
Rafael Yapparov — Chief Doctor, Republican Center for Prevention and Control of AIDS and Infectious Diseases, Republic of Bashkortostan; Chief External Expert in HIV of the Volga Federal District
27 October 15:00–16:15
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Malyy hall
Caring for the Older Generation as an Important Focus of Social Policy: The Challenge in Times of the Current COVID-19 Challenge
Maintaining an active long life and providing high-quality medical care to the elderly are important issues that shape national healthcare and social policy. In the midst of the spread of the coronavirus, older people have been exposed to greater risk, this requiring the state to develop special measures for keeping them healthy and reducing fatalities. The experience of the pandemic has shown that the State should pay close attention to all aspects that can affect the health and quality of life of older people. One way of reducing mortality and helping the elderly to maintain an active lifestyle is to prevent age-related diseases. Measures to protect the health of people beyond working age are reflected in the Federal Project “The Older Generation” of the “Demography” national project. It is a comprehensive approach and policy aimed at improving medical care for the older generation, which can become a key factor in achieving the national goal of preserving the population, health and well-being of people and increasing life expectancy in Russia.
• What state policy measures in relation to older citizens should ensure attainment of national goals of preserving health and increasing life expectancy?
• What solutions and cutting-edge technologies can increase the quality of medical and preventive care for the older generation?
• What new trends and innovative approaches in healthcare are most relevant for slowing down the rate of aging and increasing life expectancy?
• Does the Federal Project “The Older Generation” need to adjust the action plan in order to improve the quality of medical care for elderly patients?
Moderator:
Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Panellists:
Olga Batalina — Deputy Minister of Labour and Social Protection of the Russian Federation
Alexander Gubin — Director, National Medical Research Center for Traumatology and Orthopedics named after N.N. Priorova of the Ministry of Health of the Russian Federation
Vladislav Nigmatulin — Deputy Governor of the Khanty-Mansi Autonomous District – Yugra
Aleksandr Rozanov — Head, Federal Center for Coordination of the Activities of the Subjects of the Russian Federation for the Development of the Organization of Medical Care in the Geriatrics Profile
Olga Tkacheva — Director, Russian Clinical and Research Center of Gerontology of the Pirogov Russian National Research Medical University (RNRMU) of the Ministry of Health of the Russian Federation
Olga Tkacheva graduated with honours from S.M. Kirov Gorky State Medical Institute majoring in General Medicine and the therapy internship in S.M. Kirov Gorky State Medical Institute. In 1993, Olga Tkacheva was awarded the scientific degree of Candidate of Medical Sciences, in 1999 – Doctor of Medical Sciences. In 2006, she earned the title of professor. Ms Tkacheva has 32 years of clinical work experience and 28 years of teaching under her belt.
From 2013 to 2018 – Senior Geriatrician of the Ministry of Healthcare of the Russian Federation. From 2015 – present – contracted Chief Geriatrician of the Ministry of Healthcare of the Russian Federation and Director of Russian Clinical Research Centre for Gerontology. She is the author of more than 300 scientific publications, 11 monographs, national guidelines, has one certificate and three patents for inventions.
She headed the working groups and was a member of expert committees on the preparation of national guidelines ‘Diagnosis and treatment of hypertension’, the recommendations on diagnosis and treatment of hypertension in pregnant women, national guidelines on diagnosis and treatment of cardiovascular diseases during pregnancy, guidelines on general risk reduction of disease and complications in women, practical guidelines on the use of hormone replacement therapy in peri- and postmenopausal women, national guidelines ‘Prevention of chronic non-communicable diseases’, guidelines for physicians ‘Basic Principles of the prevention and treatment of thrombosis in tables and charts’, guidelines ‘Follow-up monitoring of patients with chronic non-communicable diseases and high-risk patients’.
Olga Tkacheva’s scientific research focused on the mechanisms and patterns of the heart and blood vessels ageing and their correlation with cellular replicative ageing, the issues of the age-related metabolic disorders, prevention and treatment of age-related diseases and geriatric syndromes.
She advised on 20 candidate and five doctoral theses.
She is the president of the National Public Organization ‘Russian Association of Gerontologists and Geriatricians’, member of the National Public Organization ‘Russian Society for the Prevention of Non-Communicable Diseases’, National Public Organization ‘Russian Society of Cardiology’, National Organization ‘Russian Medical Society on Arterial Hypertension’, National Medical Society of Preventive Cardiology, European Society of Cardiology, European Geriatric Medicine Society.
She is a member of the editorial board of medical journals ‘Rational Pharmacotherapy in Cardiology’, ‘Preventive Medicine’, ‘Clinical Gerontology’, ‘Archives of Internal Medicine’, ‘Medical Care’, ‘Women’s Health Issues’, ‘Russian Open Medical Journal’, ‘Bulletin of the Ivanovo Medical Academy’.
Front row participants:
Anatoly Ovsyankin — Chief Physician, Federal Center of Traumatology, Orthopedics and Endoprosthetics of the Ministry of Health of the Russian Federation (Smolensk)
Elizaveta Oleskina — Director, Old Age for Joy Charitable Foundation
Graduate of Faculty of Philology, Lomonosov Moscow State University, founder and director/CEO of “Enjoyable Ageing” charitable fund, a non-profit organisation aimed at helping elderly and disabled people, member of the Council on Guardianship under the Government of the Russian Federation. The foundation led by Elizaveta provides psychological, financial, medical, social and welfare support as well as information and advice to elderly people in difficult situations. Currently the foundation is collaborating with 25 regions, supervising 150 care homes, paying the wages of 160 carers, training the staff for care organisations. Apart from that, the fund is setting up a reliable home care service. It was “Enjoyable Ageing” that initiated the establishment of public long-term care system in Russia and is now actively participating in developing its mechanisms. Since 2018 the foundation will be part of the Federal pilot project of implementing the LTC system in accordance with the President’s order.
Igor Shubnyakov — Deputy Director for Regional Relations, Russian Scientific Research Institute of Traumatology and Orthopedicsnamed after R.R. Vreden of the Ministry of Health of the Russian Federation
27 October 15:30–16:45
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Presidential hall
Creative Industries and Medicine: Is There Scope for Synergy?
EAWF Lounge (Eurasian Women’s Forum): Creative Industries for a Healthy Society Creative innovations have stepped confidently into modern healthcare: today's medical science and the healthcare system rely increasingly on a creative approach to resolving various problems. Virtual and augmented reality technologies are used for high-tech diagnostics, which can reduce the protracted patient rehabilitation process. Artificial intelligence, processing huge amounts of information, helps the physician make the right decisions, reducing the number of medical errors. With the help of digital technologies and robotics, the quality of healthcare is improved, which means a better quality of life for patients. Smart services of the Internet of medical things not only help to control health but also create conditions for convenient prevention, strengthening the vector of preventive medicine development. A creative approach to development and use of medical technologies and scientific knowledge has allowed participants in the healthcare system to apply a symbiosis of different medical practices, seek new formats for medical care and get answers to questions that recently seemed unsolvable. By attracting innovative technologies in medicine, such as access to big data, and developing genetic science with their help, it is at last possible to talk about personalised medicine, in which prevention, diagnostics and treatment methods are developed on the basis of the individual patient’s characteristics. Thanks to the industry of creative ideas, medicine may be discussed not in the context of treating patients but rather in preventing diseases and leading healthy lifestyle as social behaviour norms.
• Will the 2020 pandemic create an even more powerful impetus for integrating the creative sector with the public healthcare system?
• How can creative industries help develop the health and medical sector?
• Will integration of the creative sector into the healthcare system require improvements to the current legislation?
• What examples of successful collaboration exist today and which areas of the healthcare system require more "creative potential"?
Moderator:
Sergey Shnurov — General Producer, RTVI; Musician, Poet
Panellists:
Marina Abramova — Director, Roskulttsentr
Oksana Drapkina — Director, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks
Elena Zhidkova — Head, Central Healthcare Directorate, Russian Railways
In 2009 Elena Zhidkova graduated from the I.M.Sechenov Moscow Medical Academy. In 2011 Ms.Zhidkova completed a residency training at the Department of Healthcare Management on the Faculty of Economics and Healthcare Management of the I.M.Sechenov First Moscow State Medical University. In 2011 Elena Zhidkova graduated from the Marketing Faculty of the Moscow State University of Economics, Statistics and Information Technology.
In 2011-2015 Ms.Zhidkova was on postgraduate study at the Department of Healthcare and Pharmaceutical Management of the I.M.Sechenov First Moscow State Medical University. Elena Zhidkova is an author of numerous articles and publications.
Since 2011 – Deputy Head of Division of Medical Services at the Morozov City Clinical Hospital for Children, since 2013 – head of consultative and diagnostics centre, in 2014 – became head of the ambulatory and polyclinic center of this organization. In 2016, Ms.Zhidkova was appointed Head of the Healthcare Department of JSC Russian Railways. Since May 2016, she is the Head of Central Healthcare Directorate – a branch of JSC Russian Railways. Since January 2017 – Chairman of the Board of Directors of the Stock Company RZD Health.
Galina Karelova — Deputy Chairman of the Federation Council of the Federal Assembly of the Russian Federation
Deputy Chairperson of the Federation Council of the Russian Federation
Born on 29 June 1950 in the city of Nizhnyaya Salda, Sverdlovsk Region. In 1972, she graduated from the Sergei Kirov Urals Polytechnic Institute with a degree in engineering and economics. PhD in Economics and DSc in Social Sciences, professor. For 20 years she was engaged in teaching and research. Author of over 150 papers on economic, social and political issues.
Since 1990 – delegate, Deputy Speaker (1992–1993) of the Sverdlovsk Regional Parliamentarian Council.
1994–1996 – Deputy of the Council of Federation of the Federal Assembly of the Russian Federation, Chairperson of the Federation Council Committee on Social Policy.
1996–1997 – Deputy of the State Duma of the Federal Assembly of the Russian Federation, Chairman of the Subcommittee on International Humanitarian, Scientific and Cultural Cooperation of the State Duma Committee on International Affairs.
Since 1997 – Deputy and since 2000 – First Deputy Minister of Labour and Social Affairs of the Russian Federation.
April 2003 – March 2004 – Deputy Prime Minister of the Russian Federation on Social Affairs.
April 2004 – December 2007 – Chairperson of the Social Insurance Fund of the Russian Federation.
On 2 December 2007, she was elected a deputy to the Fifth State Duma, Deputy Speaker of the State Duma Committee on Budget and Taxes.
On 4 December 2011, she was elected a deputy to the Sixth State Duma, First Deputy Chair of the State Duma Committee on Labour, Social Policy and Veteran Affairs.
Since 22 September 2014, she is a Representative of the executive authority of the Voronezh Region in the Federation Council. Deputy Speaker of the Federation Council of the Federal Assembly of the Russian Federation, member of the Federation Council Committee on Social Policy. Initiator and drafter of more than 40 laws, including laws on social protection. Full State Counsellor 1st Class of the Russian Federation. Decorated with state orders and medals.
Natalya Komarova — Governor of Khanty-Mansi Autonomous Area–Yugra
Natalia Komarova was born on the 21st of October 1955 in Pskov Region, she is married and has two children. In 1978 she graduated from Kommunarsk Institute of Mining and Smelting, the faculty of Engineering and Economics, majoring in “Economics and organization of construction” with awarding of qualification Engineer-economist. She began to work at the Kommunarsk Metallurgical Factory as a labor engineer of the laboratory of industrial engineering in 1978. Then she worked as an economist of the planned-economic CCB department. In 1980 Natalia moved to Novy Urengoi of Tyumen Region, Yamalo-Nenets Autonomous Okrug. There she began to work in the municipal executive committee as a senior inspector. In 1988 Natalia became the chairwoman of the city planning commission. Then she worked as the deputy chairwoman of the municipal executive committee, the deputy of the City Council. In 1992 she became the first deputy of the Head of Administration in Novy Urengoi. In 1994 Natalia was designated as the Head of the city Administration. That year she was elected as a deputy of the State Duma of Yamalo-Nenets Autonomous Okrug and as a deputy of the NoviyUrengoy Municipal Committee. On the 16thof March 1997 Natalia Komarova continued working as the Head of the municipal formation of NoviyUrengoy up to October 2000 according to the elections results. From October 2000 to December 2001 Natalia worked as a deputy of the Governor of Yamalo-Nenets Autonomous Okrug, leading the Economic Committee of the Okrug. At the same time Natalia lectures at the University: she is an associate professor of the Social Management of the Yamal Oil and Gas Institute (branch) of the Tyumen State Oil and Gas University (since 1999). In December 2001 Natalia was elected as a Deputy of the State Duma of the Federal Assembly of the Russian Federation inYamalo-Nenets Autonomous Electoral Okrug. From 2004 to 2007 she is the Head of the Natural Resources and Nature Management Committee of the State Duma of the Federal Assembly of the Russian Federation. In December 2007 Natalia was elected as the deputy of the State Duma of the Federal Assembly of the Russian Federation in Yamalo-Nenets Autonomous Electoral Okrug for the third time. In the State Duma of the fifth assembling she continued to be the Head the Natural Resources and Nature Management Committee. On the 8thof February 2010 the President of Russian Federation Dmitry Medvedev submitted a proposal to the deputies of the Khanty-Mansiysk Autonomous Okrug Duma a candidature of Natalia Komarova as the Governor of the Khanty-Mansiysk Autonomous Okrug –Ugra. At the unscheduled meeting on the 15thof February the deputies in a unanimous vote voice supported her candidature.On the 1stof March Natalia entered the office of the Governor of the Khanty-Mansiysk Autonomous Okrug –Ugra.
Simon Matskeplishvili — Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology
Simon Matskeplishvili, MD, PhD, FESC, FACC, is a Professor of Cardiology and a Chief Scientific and Clinical Researcher at the Bakoulev Scientific Center for Cardiovascular Surgery in Moscow and an adjunct professor of life sciences at the Moscow Institute of Physics and Technology.
He also serves as a member of the Education, Certification and Accreditation, European Communities Committees of the European Association of Cardiovascular Imaging.
He graduated with honors from the Moscow Medical Academy in 1994 and had his postgraduate training and fellowship in cardiology at the Clinico-Diagnostic Department of the Bakoulev Center.
In 1997-1998 he received a degree of the International Master in Cardiology from the Institute of Clinical Physiology of the National Research Council of Italy in Pisa.
Simon Matskeplishvili is a Fellow of the European Society of Cardiology and a Fellow of the American College of Cardiology. He has received numerous honours and awards, both in Russia and internationally, including the European Cardiology award in 2001. He is a founder and a Chairman of the echocardiography section of the Russian society of cardiology. In 2007 he became a full professor of cardiology.
For the development of new non-invasive method of intracardiac blood flow evaluation in 2012 he was awarded a State Prize of the Government of Russian Federation in science and technology.
In 2013 he was a captain of the Russian team to win an ESC Cardiology Quiz “Primus inter pares” at the European Congress of Cardiology in Amsterdam.
In 2012 Professor Simon Matskeplishvili had organized and implemented the Educational Program for cardiologists and internal medicine physicians in Moscow. He also conducts an English-language elective course “Amazing Cardiology” in cardiology, cardiac surgery and cardiovascular imaging at the Faculty of Medicine of the Lomonosov Moscow State University.
The Board of the European Society of Cardiology has appointed Simon Matskeplishvili as the Coordinator of the Congress Programme Committee of the European Society of Cardiology Congress 2015-2016.
Ekaterina Pogodina — Director General, Johnson & Johnson Russia & CIS, Managing Director, Janssen, pharmaceutical division of Johnson & Johnson, Russia & CIS
Katerina began her career with Janssen in 2001, holding a number of positions in the Sales, Marketing and Market Access teams. She has been a member of the Russian board of directors since 2010 and was appointed Country Manager Russia in 2015, and then she was promoted to the position of Managing Director Russia & CIS in 2017. In April 2019 Katerina was appointed CEO of Johnson & Johnson Russia & CIS.

Throughout her 17-year career with Janssen, Katerina has consistently demonstrated high standards of quality and strong results. She led the launch of a whole range of new products and work across a number of therapeutic areas, as well as establishing several new business units. In her role as Commercial Operations Director, Russia, Katerina successfully led commercial teams in close collaboration with other departments, which yielded great business results and drove the company’s overall success.

Katerina graduated with distinction from the International University in Moscow, where she studied law. She also completed specialist education for senior executives at the London School of Economics and Political Science and Moscow School of Management Skolkovo.

Since 2015 Katerina has been a member of the board of directors of the Association of International Pharmaceutical Manufacturers (AIPM). Forbes magazine contributor, speaker of the Second Eurasian Women’s Forum.
Dmitry Khankin — Founder, Triumph Gallery
27 October 16:45–18:00
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Malyy hall
Modernization of the Personnel Support System as a Response to the Challenge of Our Times
The pandemic has highlighted significant shortcomings in healthcare systems around the world, which has contributed to the need to make serious decisions very quickly. One of the problems that became apparent in the early exponential spread of COVID-19 was a shortage in the talent pool and a shortage of physicians. It was crucial to not only solve the problem of repurposing medical institutions as quickly as possible, but also mobilizing doctors and healthcare workers to combat the novel coronavirus infection. The government managed to prepare the entire medical community to work with COVID-19 patients in a short period of time. More than one and a half million people were retrained using interactive educational modules. Volunteers and senior medical students were recruited to work in infectious diseases hospitals. The Russian government has developed measures to support doctors involved in combatting coronavirus. The experience acquired during the pandemic has resulted in unprecedented professional cohesion, but the example of the specialization of infectious disease doctors has also demonstrated the shortcomings of the staffing system and, perhaps, revealed imperfections in the highly specialized approach to the medical profession and pointed to the need to shift the focus towards an interdisciplinary approach. In President Putin’s address to the Federal Assembly of the Russian Federation, training and recruiting medical personnel as well as the availability of medical education were among the top priorities. Today, these goals have become even more relevant and important. The time has come to assess whether the current human resources are sufficient for the challenges of today’s reality.
• Will the pandemic become a catalyst for the thorough modernization of the medical training system? Will the introduction of an interdisciplinary approach become another module of medical education reform?
• What skills should the doctors of the future have?
• How can we prepare our human resources for possible future epidemics?
• Is the medical education system ready to change according to the challenges of the current times?
Moderator:
Muslim Muslimov — Founder, Klinika No. 1 Medical Centre Network; Chairman of the Committee for Medical Services, Delovaya Rossiya (Business Russia); Chairman, Association of Healthcare Managers
Panellists:
Elena Aksenova — Director, Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department SBI
Valery Vechorko — Chief Doctor, Municipal Clinical Hospital No.15 named after O.M. Filatov of Department of Health of Moscow
Valery Vechorko graduated from Minsk State Medical Institute specializing in Medical and Preventive Care in 1999. He completed an internship in Dermatovenerology. In 2006, he underwent professional retraining at I.M. Sechenov First Moscow State Medical University, specializing in Internal Medicine. In 2010 he completed a training program Public Health and Healthcare.
In 2012 Valery Vechorko got a PhD degree in Medicine. Totally, he has been working for 20 years in Healthcare and for 9 years in Moscow Healthcare. Since June, 2016 Valery Vechorko has been managing City Clinical Hospital No. 15 named after O.M. Filatov. He is an Associate Professor of Inpatient Treatment Department of Russian National Research Medical University named after N.I. Pirogov.
In 2016 he graduated from Moscow Metropolitan Governance University and got a degree of Master of Public Administration (МРА) in Healthcare.
Valery Vechorko was awarded with the Badge of Honor Blagodaryu(Gratitude) by the Governor of the Moscow Region. He has a Certficate of Honour of the Russian Ministry of Health and numerous municipal and federal awards.
He is an Honorary Donor of Russia.
Valery Vechorko is married and has four daughters.
He has been a member of Russian political party UNITED RUSSIA since 2003.
Sergey Morozov — Chief External Expert in Radiation and Instrumental Diagnostics, Director, Scientific and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow City Health Department
Tatyana Semenova — Deputy Minister of Health of the Russian Federation
Ruslan Khalfin — Director, Higher School of Healthcare Management, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Ruslan Khalfin is Director of the Higher School of Healthcare Management at the I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, a medical doctor, Professor, winner of a State Prize of the Russian Federation in the field of science and technology, Honoured Doctor of the Russian Federation, and Actual State Councillor of Russian Federation, 2nd class. He worked for more than 30 years in healthcare in the Sverdlovsk Region. He has also worked in the central office of the Ministry of Health of the Russian Federation and the Ministry of Health and Social Development of the Russian Federation, and has held the post of Deputy Minister under three federal ministers. He has been actively involved in reforming the sector, and was one of the originators and implementers of the national ‘Health’ project. For the past 11 years he has been President of the medical insurance company MAKS-M, part of the MAKS Insurance Group. Chair of the Board of the Russia-wide public organization ‘The Russian Association for the Organization of Health and Public Health’.
Front row participants:
Alexander Lindenbraten — Deputy Chairman of the Academic Council, Federal State Budgetary Scientific Institution “National Research Institute of Public Health named after N.A. Semashko "
Victoria Madianova — Director of the Department of International Health Projects, Institute of Leadership and Healthcare Management, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Alexey Mozalev — Deputy Minister of Health of Nizhny Novgorod Region
27 October 16:45–18:00
 RIA Novosti, Moscow, Zubovsky Boulevard, 4с1, Bolshoy hall
Availability of Medicines: Intellectual Property Protection as a Strategy Tool
Today, the task of ensuring availability of vital medicines for all categories of the population remains a priority and of major importance for the national public healthcare system. Moreover, although vital medicines are at the forefront, it is no less urgent to ensure unhindered and timely provision of affordable innovative medicines for the medicine market. The mortality rate among the population depends on growth of innovative solutions to various life-threatening diseases, so the health system needs to encourage the pharmaceutical industry to develop effective and safe innovative medicines. One incentive to innovation and a pharmaceutical industry with investment appeal, able to resolve the challenges of increasing healthy life expectancy, is the system of intellectual property protection. The imperfections in of the system for protecting the rights of patent holders can hinder significantly the progress of innovative technologies and the availability of innovative medicines. A balance must be achieved between the interests of the state and of patients, specifically, to provide the market with affordable, high-quality, safe and effective medical products in a timely manner. This approach will not only stimulate economic development but also preclude serious social risks.
• Taking into account current realities and opportunities, how can we make sure the medicines the population needs are available?
• What strategies should Russia choose for managing intellectual property in the pharmaceutical industry, taking into account achievement of national development goals and objectives for development of an innovative pharmaceutical industry?
• How could the establishment of a unified Eurasian patent registry protect the patient community and guarantee effectiveness and safety of innovative medicines in circulation?
• What are the current opportunities, problems and solutions in the field of intellectual property regulation?
• What legislative tools could be used to ensure the most effective balance of interests?
Moderator:
Dmitry Khalilov — Partner, Life Sciences & Health Leader, Central, Eastern and Southeastern Europe & Central Asia, EY
Over 20 years of experience in providing tax advisory services to pharmaceutical and health companies; experience in managing advisory engagements for international and Russian companies in the areas of Russian and international tax planning and tax optimization, structuring of operations, cross-border and domestic transactions and other ongoing tax issues, as well as launching an IPO on international financial markets; major clients include Takeda (Nycomed), Novo Nordisk, Abbott Laboratories, Astellas Pharma, AstraZeneca, Berlin-Chemie/Menarini, Teva, Johnson & Johnson, Pfizer, UCB, Merck, Pharmstandard, Novartis.Member of an organizational committee of the interactive discussion platform Viable Healthcare, established by The Russian Presidential Academy of National Economy and Public Administration (RANEPA) and The Business Administration of the President of the Russian Federation.
Moscow State Academy of Law, degree in Tax Law; Moscow institute of State and Corporate Management, Bachelor’s degree in Economics
Panellists:
Grigory Ivliev — Head, Federal Service for Intellectual Property (Rospatent)
Mr. Ivliev was born in Paniki, Ryazan Region on 27 September 1957
1981 – Graduated from the Lomonosov Moscow State University
1984 – PhD in Law
1985-1994 – served in different capacities in Moscow State Law Academy
1994-1997 – Committee of the State Duma on Legislation and Judicial and Legal Reform, Legal Department of the State Duma
1998-2002 - Central Office of the Government of the Russian Federation, Deputy Head of the Department for Relations with the Federal Assembly, NGOs and Religious Organizations
2002-2007 - State Duma, Head of the Legal Department
2007- 2011 - State Duma Deputy of 5th convocation
2011-2015 - State Secretary and Deputy Minister of Culture of the Russian Federation.
Since 2015, Head of the Federal Service for Intellectual Property (Rospatent).
Honored Lawyer of the Russian Federation, PhD in Law, Associate Professor, Secretary of the Union of Writers of Russia.
Vadim Kukava — Executive Director, Innovative Pharma Association of Pharmaceutical Companies
In 2012, Vadim Kukava was offered the position of Executive Director of the Association of leading global innovative pharmaceutical companies, InPharma. During this time, the Association has become a key player in the Russian pharmaceutical market, collaborating with government bodies to develop balanced regulations of the industry for the benefit of Russian patents.
From 2006 to 2012, Vadim worked in leading international companies that produce consumer goods, in positions connected to public/GR relations and policy affairs. During this time, Vadim participated in discussions on key legislation in the sphere of regulating the tobacco and medical industries, collaborated with representatives of the Russian and European scientific communities, and played an active role in the work of industrial associations, including on the Board. In addition, Vadim was responsible for creating and developing a division for public and regulatory affairs.
From 2004 to 2006, he worked as a consultant at the Federal Agency for State Property Administration (Rosimuschestvo). Vadim was responsible for implementing the full range of powers of ownership related to property within the forestry and chemical industry owned by the Russian Federation.
In 2003, he graduated from the Faculty of Law of the International University in Moscow.
Alexey Repik — Chairman, Delovaya Rossiya (Business Russia); Chairman of the Board, Group R-Pharm
Born in Moscow, Russia on 27 August 1979.Graduated from the State University “Higher School of Economics”, Diploma in Economy and Business Administration.Since 1995 in Healthcare and Pharmaceutics.R-Pharm Founder. President of All-Russia Business Association “Delovaya Rossiya” (“Business Russia”), actively participating in the improvement of investment climate in the Russian Federation and the establishment of the regional investment standard.Member of the Economic Council under the President of the Russian Federation.Member of the Presidential Council for Priority National Projects and Demographic Policy.Member of the Expert Council under the Government of the Russian Federation. Member of the Public Chamber of the Russian Federation, Head of Commission on Investment Climate.Representative (public ombudsman) of the Commissioner of the Presidential Council on the protection of the rights of entrepreneurs on issues related to the protection of the rights of foreign investors.Board-member and Co-chairman of Committee of the Russian Union of Industrialists and Entrepreneurs on pharmaceutical and medical industry.Co-Chairman of the National Rating CommitteeMember of the Public Council under the Ministry of Industry and Trade of the Russian Federation (pharmaceutical, medical equipment and technologies).Member of the Supervisory Board of the Autonomous Nonprofit Organization "Agency for Strategic Initiatives".
Filipp Romanov — Director of the Department of State Regulation of Medicines Circulation, Ministry of Health of the Russian Federation
Front row participant:
Irina Lavrova — Head of Communications, Government Relations and Sustainable Development, Bayer Russia